Acturadar.comFrance in real time

Detected on Monday 16 November, 14h00

Debate on access to new medicines and quality of care

An opinion piece argues that the quality of care should not be measured solely by access to new medicines, while the pharmaceutical industry calls for faster authorizations. The debate takes place during the examination of the Social Security Financing Bill (PLFSS) in Parliament.

In brief

Health event (severity: notable) nationwide, first detected on 16 November 2026 at 14:00. Reported by 1 source (1 article), last updated on 16 November 2026 at 14:00.

·
Category
Health
Severity
Notable
Place

National

Detected
16 Nov, 14h00
Updated
16 Nov, 14h00
Reference
no.21789
01

Who is covering it, and from what angle

Method
1Left

1 article · 1 source · 1 bord sur 3 · outlets: left 1, centre 0, right 0

Angle comparison

A comparison is written as soon as the event is covered by at least two sides (left, centre, right).

02

Lire les sources · 1 article, 1 source

Publication order
  1. 14h00
    Le MondeCentre-leftOpinion16 Nov
    En France, la qualité des soins ne saurait se mesurer à l’accès aux nouveaux médicaments

    L’industrie pharmaceutique réclame des mises sur le marché plus rapides pour ses médicaments, arguant d’une perte de chance, non vérifiée, pour les Français. A l’heure où le projet de loi de financement de la Sécurité sociale est examiné au Parlement, les entreprises tentent de faire bouger les lignes en leur faveur.

03

Further reading